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The role of maternal antibodies is to protect newborns against acute early infection by pathogens. This can be
achieved either by preventing any infection or by allowing attenuated infections associated with activation of the
immune system, the two strategies being based on different cost/benefit ratios. We carried out an epidemiological
survey of myxomatosis, which is a highly lethal infectious disease, in two distant wild populations of rabbits to
describe the epidemiological pattern of the disease. Detection of specific IgM and IgG enabled us to describe the
pattern of immunity. We show that maternal immunity attenuates early infection of juveniles and enables activation
of their immune system. This mechanism associated with steady circulation of the myxoma virus in both populations,
which induces frequent reinfections of immune rabbits, leads to the maintenance of high immunity levels within
populations. Thus, myxomatosis has a low impact, with most infections being asymptomatic. This work shows that
infection of young rabbits protected by maternal antibodies induces attenuated disease and activates their
immune system. This may play a major role in reducing the impact of a highly lethal disease when ecological
conditions enable permanent circulation of the pathogen.Introduction
A same infectious agent may induce in vertebrates a
large range of clinical signs from asymptomatic to a se-
vere disease that may even lead to death. A first factor
usually involved in the severity of a disease is the im-
munological status of the host. Following a primo-
infection, the duration of acquired immunity is highly
variable [1,2]. However, reinfections occurring before the
acquired immunity has waned may lead to attenuated
diseases if residual immunity is sufficient and reactivate
the immune system, thereby extending the acquired im-
munity. Therefore, in situations where a pathogen circu-
lates efficiently within the host population, individuals* Correspondence: stephane.marchandeau@oncfs.gouv.fr
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article, unless otherwise stated.are steadily reinfected and maintain a high level of im-
munity. In these cases, individuals may develop only one
event of severe disease at their first exposure to the
pathogen, which is likely to occur early in life at a mo-
ment that is particularly critical because the newborn
lack a fully efficient immune system. To limit the conse-
quences of an early first infection, several mechanisms
can attenuate its effect, in particular the transfer of ma-
ternal antibodies to the newborn [3].
Despite abundant literature on the evolution of host
defense mechanisms against infectious agents (Review in
[4]), the effect of the transfer of maternal immunity has
attracted increasing attention only recently [5-11]. Sev-
eral studies have demonstrated that maternal antibodies
block the infection in the case of an early exposure to
the parasite and inhibit the offspring immune response
[12]. This blocking effect is responsible for unsuccessful
vaccination in newborns [13-15]. In this case maternalentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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ease dynamics [16]. However, other studies have shown
that, in cases of early infection, maternal antibodies can
only reduce the severity of the disease, thereby enabling
the host immune system to develop acquired immunity
without the cost of a severe disease [17-20], as initially
proposed by Zinkernagel [21,22]. Maternal immunity
may also have long-term effects: even in the absence of
early infection, individuals born with maternal antibodies
may display an enhanced immune response when infec-
tion occurs after maternal immunity has waned [23-25].
In addition, maternal immunity may even have positive
trans-generational effects on offspring of females having
received maternal antibodies from their own mother
[25]. Most of these studies on maternal immunity have
focused on the individual level but little is known about
the potential effect of maternal immunity on disease dy-
namics and impact at the population level.
The European rabbit (Oryctolagus cuniculus) and myx-
omatosis system has been widely studied and is consid-
ered to be a classical example of coevolution [26,27].
Myxomatosis is a viral disease due to a Leporipoxvirus,
which is responsible for a lethal disease in European rab-
bits and was introduced in several countries in the
1950’s to fight against wild rabbit pullulations: in 1950 in
Australia after several unsuccessful attempts [28] and in
1952 in France [29] from where it spread throughout
south-western Europe. The initial impact of the disease
in France was strong and mortality rates were estimated
at 90-95% [28,30]. Then, populations have steadily re-
covered as a result of a coevolution between the host
and its pathogen [26,27,31-33]. Today, the impact of
myxomatosis varies a lot, with populations where mor-
talities due to the disease are high and others with per-
manent and strong immunity levels where the disease
has a very low impact, characterizing epizootic and en-
zootic patterns of the disease, respectively [34,35].
Changes in the virulence of myxoma virus (MYXV) were
observed shortly after the introductions of the virus
[36,37], with multiples genes being involved in changes
in virulence [38]. The development of rabbit genetic re-
sistance to the disease has been suggested in Europe
[39,40] but it is controversial and anyway, of marginal
effect [41-43]. In addition, development of immunity in
the populations, which may be part of the coevolution
process [44], is the third factor that has led to a decrease
of the impact of the disease [26]. However, the charac-
teristics of immune response in wild rabbits remain
poorly documented. Its length and intensity depend on
rabbits, likely under genetic control [45], and viral
strains [46]. In laboratory conditions, some rabbits show
detectable residual antibodies one year after inoculation
of the virus [46]. In wild populations, some studies have
shown that rabbits may be seropositive over longerperiods, up to 19–24 months, but these long immunities
could be due to undetected natural reinfections [32,47].
Maternal antibodies remain detectable up to 6 to 9 weeks
after birth [47].
The persistence of high immunity levels in the popula-
tions, which is the result of an endemic pattern of the
disease, has been shown in large populations [34,35,48].
In such populations, rabbits with symptoms of myxoma-
tosis are observed throughout the year, with most of
them showing mild clinical signs. These data suggest
that most rabbits are partly protected at the time of their
first exposure to the virus, otherwise some cases of se-
vere disease should be observed. Modelling the mechan-
ism described by Zinkernagel [21,22] explains these
observed patterns of the disease. The mean severity of
the disease depends on the transmission rate of the
virus: high transmission rates lead to early infections of
juveniles, steady reinfections, and maintenance of high
immunity levels in the populations throughout the year
[9,11]. In contrast, low transmission rates do not enable
the maintenance of high immunity levels and lead to the
epidemic pattern of the disease with a first infection oc-
curring when maternal immunity has waned.
The aim of the present study was to highlight the
Zinkernagel’s mechanism under natural conditions in the
rabbit/myxomatosis system, which is a good model since
juveniles are known to be highly susceptible to the disease
and show severe disease even when infected by attenuated
MYXV strains [49,50]. To this end we caught rabbits over
three years in two wild populations to analyse the pattern
and the role of immunity, and especially of maternal im-
munity, on the epidemiology and impact of myxomatosis.
For this purpose, we detected specific anti- MYXV IgM
and IgG, which allowed us to characterize MYXV cir-
culation in both populations and to describe its effect
on immunity at both individual and population levels,
IgM being an indicator of recent infection and IgG per-
sisting over several months after infection [47]. In
agreement with Zinkernagel [21,22], we predict that if
maternal immunity protects against severe myxoma-
tosis while permitting to the juveniles to activate their
own immune system, we should observe asymptomatic
or mild myxomatosis in juveniles less than two months
old before maternal immunity has waned. Alterna-
tively, if maternal immunity has a blocking effect, then




The study was carried out on two study areas. Aubas
(1°11′W, 45°4′N, Department of Dordogne) is situated
in south-western France. The landscape is a cultivated
open land constituted mainly of maize and walnut fields.
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temperature is 11.5 °C. Density is around 5 rabbits/ha in
this population. Saint Benoist (1°53′ E, 48°42′ N, De-
partment of Yvelines) is located in central France. The
landscape is a cultivated open land with coppices. Farm-
ing practices, crops and field margin strips are managed
for game. Mean annual rainfall is 630 mm and mean an-
nual temperature is 10.1 °C. The density is lower (1–2
rabbits/ha) in Saint Benoist than in Aubas.
We trapped rabbits over three years to record data on
myxomatosis events and on immunity (2002–2005 in
Aubas, 2001–2004 in Saint Benoist). Trapping sessions
were organized every five weeks and lasted two weeks
each. Rabbits were caught in wire cage traps and indi-
vidually marked. At each capture, each rabbit was
weighed and a blood sample was taken on a strip of
blotting paper [51,52]. Clinical signs of myxomatosis
were also recorded. If any, they were distributed into 3
classes: severe (tumours ≥ 5 mm, presence of secondary
lesions), mild (tumours < 5 mm, no secondary lesion),
recovered (tumours in healing or healed). Rabbits from
Aubas were recorded as Axx and rabbits from Saint
Benoist as SBxx, where xx is the rabbit number.
Age determination in juveniles
Rabbits were considered as juveniles until the beginning
of the next breeding season, i.e. until the end of the cal-
endar year of their birth. Afterwards individuals were
considered as adults. To study maternal immunity, we
considered maternal antibodies to be detectable up to
8 weeks. Indeed, it has been shown that they persist up
to 6 to 9 weeks, depending on the individual and on the
antibody titre of the mother [47]. We used the body
weight to determine the age of the juveniles [53]. The
mean weight of an 8 weeks old rabbit is about 430 g in
females and 470 in males.
Serological tests
The serological responses against MYXV were evaluated
using enzyme-linked immunosorbent assays (ELISA), as
previously described [54]. Briefly, two 6 mm-diameter
discs of blotting paper impregnated with blood were
rehydrated in 100 μL of phosphate-buffered saline (PBS)
in a 96-well microplate and stored at 4 °C overnight.
The eluate was then used directly in serological tests as
equivalent to a 1/20 dilution of fresh serum. ELISA plate
wells (Falcon Probind, Becton Dickinson, Le Pont de
Claix, France) were coated with 1 μg of semi purified
MYXV. The specific MYXV antibody binding was visual-
ized by incubating the plate wells with alkaline phos-
phatase antibody conjugates (Goat anti rabbit IgM or
IgG, 1:4000, Sigma, Saint Quentin Fallavier, France) at
37 °C during 60 mn. The absorbance of each sample
was measured at a wavelength of 405 nm using aspectrophotometer 15 mn after addition of substrate so-
lution (4-nitrophenyl phosphate disodium salt in 10%
diethanolamine, pH 9.8) (Sigma). The eluate sample titre
was expressed as the inverse of the highest dilution for
which the optical density was greater than thrice the op-
tical density of the negative serum standard. Titres ≥ 50
were considered as positive. The complete data set is
given in Additional file 1.
Results
Early infections and immunity in juveniles
Most juveniles less than 8 weeks old carried IgG in
both populations (57% in Aubas, 80% in Saint Benoist)
(Figure 1). Among rabbits less than 8 weeks old with
only IgG, none showed signs of disease or recovery
(Table 1). Among those carrying both IgG and IgM
(21% in Aubas, 60% in Saint Benoist) (Figure 1), which
indicates a recent infection, only one showed clinical
signs of myxomatosis and it developed a mild disease
(Table 1).
Reinfections and reactivation of the immune system
Several rabbits showed evidence of reinfection in both
populations (Table 2). For example, rabbit A132 (adult)
had only IgG on 23 September 2003, which means that
it had recovered from a previous infection, and had both
IgM and IgG on 17 December 2003, which means that it
had been recently reinfected. It did not show any clinical
sign of myxomatosis, showing that this reinfection was
asymptomatic. Rabbit A92 (adult) had only IgG on 21
February 2003 and had both IgM and IgG on 21 November
2003 and on 20 January 2004. Since IgM are detectable
during about 3 weeks, it is likely that this rabbit had
been reinfected twice with about 2 months between the
two reinfections. Among the 9 cases of reinfection
proved by the data, only one showed clinical signs of
mild myxomatosis and two were considered recovered.
These reinfections were therefore asymptomatic or
with symptoms of attenuated myxomatosis.
Herd immunity and circulation of the virus
Due to small sample sizes, data on immunity in adults
were pooled in six-month periods for both areas. We ob-
served that the immunity level in the adult population
was permanently high on the two areas. Between July
2002 and June 2005, the proportion of adults with anti-
bodies varied between 83 and 100% in Aubas. Between
January 2002 and June 2004, it varied from 50 to 100%
in Saint Benoist (Figure 2). We used the proportion of
IgM positive rabbits, both juveniles and adults, as an in-
dicator of the virus circulation by three-month periods
(Figure 3). We recorded numerous cases of recent infec-
tion that were distributed throughout the study period
since some rabbits were caught with IgM in all seasons
Figure 1 Proportion of juveniles with IgG and IgM by weight. Aubas: a. St Benoist: b. Sample sizes are indicated above the bars. For rabbits
caught several times in the same weight class the data from the first capture was taken into account.
Table 1 Anti MYXV-antibodies and early infection in
juveniles weighing less than 600 g
Rabbit Sex Date Weight (g) Myxomatosis IgM IgG
SB89 F 25/06/2003 260 None - +
A34 M 23/05/2002 320 None - +
A58 F 24/09/2002 350 None - +
A149 F 21/11/2003 380 None - +
A143 M 16/10/2003 400 None - +
A147 F 18/11/2003 400 None - +
A148 M 20/11/2003 400 None - +
A169 M 17/03/2004 420 None - +
A144 M 17/10/2003 480 None - +
A185 M 11/05/2004 540 None - +
A100 F 19/03/2003 230 None + +
A47 M 23/07/2002 400 Mild + +
A48 M 23/07/2002 400 None + +
SB68 F 20/09/2002 400 None + +
SB88 F 25/06/2003 410 None + +
SB65 F 15/08/2002 490 None + +
A108 M 11/04/2003 500 None + +
A188 F 11/05/2004 500 None + +
SB48 M 23/07/2002 510 None + +
A164 F 15/03/2004 520 None + +
A184 F 11/05/2004 520 None + +
SB91 F 11/07/2003 550 None + +
In bold rabbits less than 8 weeks old, i.e. for which IgG likely have a maternal
origin component.
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changed over time, which shows that the intensity of
virus circulation was not constant.
Low prevalence of the disease
Overall, in Aubas, only 6.0% of adults (8/133) and 1.1% of
juveniles (1/91) were caught with clinical signs of myxoma-
tosis: three adults had signs of mild disease, the five others
had recovered and the juvenile showed signs of mild myx-
omatosis. In Saint Benoist, 7.7% of adults (3/39) were
caught with clinical signs: two had severe myxomatosis and
one had recovered. No juvenile among 41 was caught with
clinical signs in Saint Benoist.
Discussion
Our data highlight early infections without severe dis-
ease in juveniles, which gives support to Zinkernagel’s
mechanism regarding the role of maternal immunity. In-
deed, despite being constrained by the difficulty of sam-
pling in wild populations and by some uncontrolled
factors, such as the viral strains circulating in the popu-
lations, they allowed us to study the relevance of our
predictions on the mechanisms of establishment of im-
munity in juveniles and to describe the pattern of virus
circulation and the impact of the disease to the individ-
ual and population levels under natural conditions [55].
One may assume that the low prevalence of the dis-
ease, i.e. the proportion of individuals showing clinical
signs of myxomatosis, was due to the low virulence of
MYXV strains that have circulated in both of the rabbit
populations studied. Since there is no genetic character-
istic of MYXV related to virulence [38], strain virulence
is classically determined by in vivo experiments [26]. We
did not conduct these experiments for ethical and
Table 2 Changes in the serological status of rabbits caught several times during the study
Rabbit Sex Date Weight (g) Clinical signs IgM IgG Reinfection
A103 F 21/03/2003 1760 None - -
13/05/2003 1700 None - +
19/03/2004 1900 Mild + + Yes
A132 F 23/09/2003 1760 None - +
17/12/2003 1700 None + + Yes
A135 M 24/09/2003 1200 None - +
16/12/2003 1350 None + + Yes
20/01/2004 1200 None + + Possible
A136 F 24/09/2003 1400 None - +
14/05/2004 1300 Recovered + + Yes
A144 M 16/10/2003 480 None - +
17/12/2003 1100 None + +
20/01/2004 1120 None + + Possible
A55 M 21/08/2002 1400 None + +
12/09/2002 1400 None + + Possible
A92 M 21/02/2003 1360 None - +
21/11/2003 1400 None + + Yes
20/01/2004 1430 None + + Yes
SB34 F 26/06/2002 1500 None + +
17/07/2002 1500 None + + Possible
SB40 M 05/07/2002 1200 None - +
27/01/2004 1480 None + + Yes
SB74 F 30/09/2002 1400 None + +
21/11/2002 1300 None + + Yes
SB78 M 21/01/2003 1440 Mild + +
13/01/2004 1550 Recovered + + Yes
SB87 M 24/06/2003 600 None + +
22/07/2003 920 None + + Possible
When rabbits carried IgM at two consecutive captures we considered that it was the same infection if the time interval between the captures was less than
1 month. It was considered as a reinfection when the time interval between the captures was more than 1.5 month. In the other cases it was considered as a
possible reinfection.
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of circulating MYXV strains in both populations would
have required inoculating a huge number of rabbits. Sec-
ond, since myxomatosis was mainly asymptomatic in
most cases, it was not possible to identify rabbits to
sample in order to collect the virus. However, since
lowly virulent strains (grade V according to Fenner and
Fantini [26]) represent less than 5% of the MYXV strains
circulating in wild rabbits in Europe [26], it is unlikely
that such strains have circulated alone over three years
in two distant rabbit populations. Therefore, we dismiss
this hypothesis and we conclude that the low prevalence
of the disease is linked to rabbit immunity and to the
permanent circulation of MYXV.
Rabbits less than 8 weeks old carrying IgM, which indi-
cates a recent infection, only developed an asymptomaticor a mild disease, suggesting that they were partly protected
by maternal antibodies when infected. Juveniles are known
to be highly susceptible to myxomatosis and show severe
disease whatever the MYXV strain involved [49,50]. These
observations show that, in the rabbit/myxomatosis system,
maternal antibodies do not prevent rabbits from being in-
fected but attenuate infection and do not prevent an
immune response from infected juveniles. Our data there-
fore support Zinkernagel’s hypothesis in accordance with
similar observations made on other host/parasite systems
[17-20,23-25].
Moreover, these data point out that most juveniles had
maternal antibodies. The proportion of rabbits less than
400 g with IgG is high in both populations. If these IgG
were only acquired, one would have expected to observe
juveniles with signs of severe myxomatosis, which was
Figure 2 Temporal changes in the proportion of adults with IgG. Aubas: a. St Benoist: b. Data are pooled in six-month periods. Sample sizes
are indicated above the bars. For rabbits caught several times during the same period the data from the first capture was taken into account.
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infected, implying that these IgG are of maternal origin,
or they had been infected without showing any clinical
sign because they were protected by maternal antibodies
when infected. One cannot exclude that some severe
cases of myxomatosis remained undetected in juveniles
before their emergence from the nest since wild rabbits
cannot be captured at this age. However, these severe
cases are probably quite rare because of the high propor-
tion of immune adults and consequently of the high pro-
portion of maternally protected juveniles.
In addition, we showed that infections and reinfections
occur in all seasons, and that reinfections reactivate the
immune system of rabbits without any severe disease.
These reinfections may explain some results obtained in
other studies where rabbits remained seropositive overFigure 3 Temporal changes in the proportion of rabbits with IgM. Au
sizes are indicated above the bars. No rabbit was caught in 2004–2 in St Beperiods up to 36 months [34]. Our results also confirm
that secondary exposures to a poxvirus may induce an
IgM response, as previously observed during the 2003
North American outbreak of Monkeypox for people who
were vaccinated against smallpox as children [56].
These observations enable us to account for the epi-
demiological pattern of the disease in the populations
studied. They validate the expectations of the models
developed by Fouchet et al. [9,11] for analysing the re-
lationship between virus persistence and impact of myx-
omatosis in wild populations under Zinkernagel’s
scenario. They show that when the virus continuously
circulates, individuals are steadily infected and develop
mild or asymptomatic diseases that enable the reactiva-
tion of their immune system. As soon as the proportion
of immune adults is high, numerous young are bornbas: a. St Benoist: b. Data are pooled in three-month periods. Sample
noist.
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munity wanes, which is frequent with the steady circula-
tion of the virus, they also develop an attenuated disease
that leads to the development of their own specific im-
mune response. In such endemic conditions, the disease
has a low impact. In addition to the mechanisms de-
scribed by Fouchet et al. [9,11], one cannot rule out that
long-term effects of maternal immunity [23-25] have
contributed to establish a strong herd immunity and to
reduce the impact of the disease in the two populations
studied.
To conclude, this work highlights the role of maternal
antibodies in the establishment of strong herd immunity
in wild populations. It describes the mechanism whereby,
together with changes in virulence of MYXV and with
the increase of genetic resistance in rabbits, the devel-
opment of immunity in rabbit populations is responsible
for a decrease of the impact of myxomatosis [26]. The
relevance of Zinkernagel’s mechanism for the rabbit/
myxomatosis system gives strength to the predictions of
Fouchet et al. [9-11]: population size, population struc-
ture but also demographic parameters such as the
length of the breeding season play a major role in virus
persistence, which enables the maintenance of high im-
munity levels. This means that the variability of impact
of myxomatosis among populations is not only driven
by the coevolution between the virus and its host, but
also by population dynamics and the large scale spatial
structure of the populations.
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